The future is in the therapeutic use of medicines.

Global Networks

Highly experienced team with networks throughout the medicinal cannabis supply chain.

Proven Track Record

The team have been pioneers in the Australian medicinal cannabis sector establishing a number of publicly-listed companies including AusCann Group, Zelira Therapeutics and CannPal Animal Therapeutics.


License agreements in place for distribution of exclusive branded premium product into specific markets. Early mover advantage into newly emerging markets including the United Kingdom. New opportunities for partnering and value adding being explored.

Premium Product Range

Exclusive access to pharmaceutical-grade (EU-GMP) product for United Kingdom, Australia and South-East Asia markets with multiple branding options. Expanding portfolio of third party products from a variety of suppliers.

Growing Global Market

Rapid growth continues with new federally legal markets opening at an increasing pace

Capital Networks

Well established networks in the financial markets sector.

Distribution Network

Health House has an established pharmacy distribution business in Australia and the UK . Other markets to follow.

Strong Global Industry Relationships

This team have established strong relationships across the globe spanning cultivation, research, clinical trials, medical clinics, e-commerce, animal health and recreational sectors as well as in the capital markets of Canada, Australia and Europe/United Kingdom. Have founded, invested in or advised on multiple companies across the globe.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.